Cargando…
Expansion of the phenotypic spectrum and description of molecular findings in a cohort of patients with oculocutaneous mosaic RASopathies
BACKGROUND: Postzygotic KRAS, HRAS, NRAS, and FGFR1 mutations result in a group of mosaic RASopathies characterized by related developmental anomalies in eye, skin, heart, and brain. These oculocutaneous disorders include oculoectodermal syndrome (OES) encephalo‐cranio‐cutaneous lipomatosis (ECCL),...
Autores principales: | Chacon‐Camacho, Oscar F., Lopez‐Moreno, Daniel, Morales‐Sanchez, Martha A., Hofmann, Enriqueta, Pacheco‐Quito, Michelle, Wieland, Ilse, Cortes‐Gonzalez, Vianney, Villanueva‐Mendoza, Cristina, Zenker, Martin, Zenteno, Juan Carlos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503218/ https://www.ncbi.nlm.nih.gov/pubmed/30891959 http://dx.doi.org/10.1002/mgg3.625 |
Ejemplares similares
-
Management of rasopathies
por: Yoo, Han-Wook
Publicado: (2013) -
Defining RASopathy
por: Rauen, Katherine A.
Publicado: (2022) -
Nevus anemicus and RASopathies
por: Bulteel, Charlotte, et al.
Publicado: (2018) -
Neurodevelopmental Aspects of RASopathies
por: Kim, Ye Eun, et al.
Publicado: (2019) -
RASopathies and cardiac manifestations
por: Hilal, Nazia, et al.
Publicado: (2023)